AM
Angela M Cacace sold $20K of ARVN stock
Angela M Cacace, Chief Scientific Officer of Arvinas, Inc. (ARVN), sold 2,576 shares of ARVN stock worth $20K, per an SEC Form 4 filed Jun 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 17, 2026, 1 day before it was made public.
ARVN has moved -11.9% since the trade date, from $7.67 to $6.76 (Nov 9, 2026 close).
- Traded
- Jun 17, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 1 day
- Price since
- -11.9%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4